The PPAR-gamma Pro12Ala polymorphism and risk of cognitive impairment in a longitudinal study
- 31 May 2010
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 31 (5) , 741-746
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The peroxisome proliferator-activated receptor gamma (PPAR-γ2) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenariansBrain Research, 2007
- Association Analysis of Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Late Onset Alzheimer’s Disease in the Finnish PopulationDementia and Geriatric Cognitive Disorders, 2006
- Race/Ethnic Issues in Obesity and Obesity-Related ComorbiditiesThe Journal of Clinical Endocrinology & Metabolism, 2004
- Prevalence of Dementia in Older Latinos: The Influence of Type 2 Diabetes Mellitus, Stroke and Genetic FactorsJournal of the American Geriatrics Society, 2003
- Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ 2 (PPARγ 2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patientsExperimental and Clinical Endocrinology & Diabetes, 2002
- Recognition Memory and Verbal Fluency Differentiate Probable Alzheimer Disease From Subcortical Ischemic Vascular DementiaArchives of Neurology, 2001
- The Pro12→Ala Substitution in PPAR-γ Is Associated With Resistance to Development of Diabetes in the General PopulationDiabetes, 2001
- A new verbal learning and memory test for English- and Spanish-speaking older peopleJournal of the International Neuropsychological Society, 2001
- The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetesNature Genetics, 2000
- The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 DiabetesBiochemical and Biophysical Research Communications, 2000